JPS5942323A - 選択的殺細胞性蛋白複合体及びその製造方法 - Google Patents

選択的殺細胞性蛋白複合体及びその製造方法

Info

Publication number
JPS5942323A
JPS5942323A JP57151754A JP15175482A JPS5942323A JP S5942323 A JPS5942323 A JP S5942323A JP 57151754 A JP57151754 A JP 57151754A JP 15175482 A JP15175482 A JP 15175482A JP S5942323 A JPS5942323 A JP S5942323A
Authority
JP
Japan
Prior art keywords
immunoglobulin
fragment
complex
group
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57151754A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0428720B2 (esLanguage
Inventor
Kazuo Kishida
岸田　一雄
Yoshinori Kato
加藤　喜規
Masahiko Saito
斉藤　政彦
Takeshi Hara
健 原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to JP57151754A priority Critical patent/JPS5942323A/ja
Publication of JPS5942323A publication Critical patent/JPS5942323A/ja
Publication of JPH0428720B2 publication Critical patent/JPH0428720B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
JP57151754A 1982-09-02 1982-09-02 選択的殺細胞性蛋白複合体及びその製造方法 Granted JPS5942323A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP57151754A JPS5942323A (ja) 1982-09-02 1982-09-02 選択的殺細胞性蛋白複合体及びその製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57151754A JPS5942323A (ja) 1982-09-02 1982-09-02 選択的殺細胞性蛋白複合体及びその製造方法

Publications (2)

Publication Number Publication Date
JPS5942323A true JPS5942323A (ja) 1984-03-08
JPH0428720B2 JPH0428720B2 (esLanguage) 1992-05-15

Family

ID=15525559

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57151754A Granted JPS5942323A (ja) 1982-09-02 1982-09-02 選択的殺細胞性蛋白複合体及びその製造方法

Country Status (1)

Country Link
JP (1) JPS5942323A (esLanguage)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6156198A (ja) * 1984-05-23 1986-03-20 サノフイ イオノフオアと高分子とをカツプリングさせた包合体およびその使用法
JP2006056907A (ja) * 1993-10-15 2006-03-02 Conjuchem Inc 細胞および血清タンパク質アンカー並びに接合体

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6156198A (ja) * 1984-05-23 1986-03-20 サノフイ イオノフオアと高分子とをカツプリングさせた包合体およびその使用法
JP2006056907A (ja) * 1993-10-15 2006-03-02 Conjuchem Inc 細胞および血清タンパク質アンカー並びに接合体

Also Published As

Publication number Publication date
JPH0428720B2 (esLanguage) 1992-05-15

Similar Documents

Publication Publication Date Title
US4379145A (en) Antitumor protein hybrid and process for the preparation thereof
US4350626A (en) Antitumor hybrid and process for the preparation thereof
US5338542A (en) Disulfide linked immunotoxins with molecular groupings in the linker which cause steric hindrance to the disulfide linkage
EP0115171B1 (en) Conjugate having cytotoxicity and process for the preparation thereof
JPH021129B2 (esLanguage)
JPH021128B2 (esLanguage)
JP2975677B2 (ja) 架橋抗体およびその製造方法
US4919927A (en) Process for the potentiation of immunotoxins
JP3340127B2 (ja) 異常増殖性疾患措置のための抗体接合体
JPH0259128B2 (esLanguage)
PT91075B (pt) Processo para a preparacao de imunoconjungados de gelonina com anticorpos especificos de tumor apropriados para o diagnostico e a terapeutica do cancro
JPS59116232A (ja) 細胞毒性複合体及びその製造法
US6509451B1 (en) Cross-linked antibodies and processes for their preparation
EP0017507B1 (en) Antitumor protein hybrid and process for the preparation thereof
RU2127122C1 (ru) Композиция, обладающая цитотоксическим действием, способ обработки лейкозной клетки in vitro
JPH05238952A (ja) 抗体を伴う薬物のクラスター複合体
EP0023779A1 (en) Antitumor protein hybrid and process for the preparation thereof
Werlen et al. Preparation of a trivalent antigen-binding construct using polyoxime chemistry: improved biodistribution and potential for therapeutic application
JPS5942323A (ja) 選択的殺細胞性蛋白複合体及びその製造方法
JPS58167519A (ja) 細胞毒性複合体及びその製造法
JPS59134734A (ja) 殺細胞性修飾免疫グロブリン及びその製造方法
JPS62175500A (ja) 修飾糖タンパク質、当該修飾糖タンパク質の製造方法、当該修飾糖タンパク質を含む免疫毒素および当該免疫毒素を有効成分として含む抗ガン剤組成物
Myers et al. Favorable pharmacodynamic features and superior anti-leukemic activity of B43 (anti-CD 19) immunotoxins containing two pokeweed antiviral protein molecules covalently linked to each monoclonal antibody molecule
JPS611622A (ja) 細胞毒性複合体及びその製造法
Arnon Department of Chemical Immunology